Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma

Recurrent glioma treatment is challenging due to molecular heterogeneity and treatment resistance commonly observed in these tumors. Researchers are actively pursuing new therapeutic strategies. Oncolytic viruses have emerged as a promising option. Oncolytic viruses selectively replicate within tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Mingming, Liao, XuLiang, Tao, Yi, Chen, Yaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652401/
https://www.ncbi.nlm.nih.gov/pubmed/38022620
http://dx.doi.org/10.3389/fimmu.2023.1285113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652401/
https://www.ncbi.nlm.nih.gov/pubmed/38022620
http://dx.doi.org/10.3389/fimmu.2023.1285113

Ejemplares similares